GENESILICO

ent_c4a262fae8f0e8f951e5dd91

Compliance scorecard →View in feed →

Disclosures

Leak Site · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

unverified actor claims

Identity resolution

Canonical name: GENESILICO
Normalized: genesilico— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Unverified threat-actor claim — not a regulatory filing

Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.

Disclosure history (1)newest first

GLOBALLeak Siteas victim2026-09-07
GeneSilico is a Polish bioinformatics company based in Warsaw, operating within the life sciences and computational biology sector. It specializes in RNA and protein structure prediction, molecular modeling, and bioinformatics software development. The company provides research services and tools to academic and pharmaceutical clients, supporting drug discovery and genomic research. It is affiliated with the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences.